Neurohormonal perturbations in fibromyalgia (Q41205087)

28 September 2017

1 reference

title

Neurohormonal perturbations in fibromyalgia (English)

1 reference

28 September 2017

0 references

1

Crofford LJ

1 reference

28 September 2017

Engleberg NC

2

1 reference

28 September 2017

Demitrack MA

series ordinal

3

1 reference

28 September 2017

publication date

1 May 1996

1 reference

Bailliere's clinical rheumatology

28 September 2017

published in

1 reference

28 September 2017

volume

10

1 reference

28 September 2017

issue

2

1 reference

28 September 2017

page(s)

365-378

1 reference

Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

The connective-tissue diseases and symptoms associated with Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Hypothalamic receptors influencing the secretion of corticotrophin releasing hormone in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Severe fibromyalgia after hypophysectomy for Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Role of serotonin in the control of secretion of corticotrophin releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Comorbidity of fibromyalgia with medical and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Effect on various putative neurotransmitters on the secretion of corticotrophin-releasing hormone from the rat hypothalamus in vitro-a model of the neurotransmitters involved

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Regulation of the hypothalamo-pituitary axis by neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Serotonin mediation of circadian periodicity of plasma 17-hydroxycorticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Neuropeptide Y and sympathetic neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Plasma tryptophan and musculoskeletal pain in non-articular rheumatism (“fibrositis syndrome”)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Is neurally mediated hypotension an unrecognised cause of chronic fatigue?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Relation of Brain 5-Hydroxytryptamine Content to the Diurnal Variation in Plasma Corticosterone in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Corticotropin releasing factor produces behavioural activation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Fibromyalgia and menopause. Examination of the relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

A Role for Serotonin in the Hypothalamic-Pituitary-Adrenal Response to Insulin Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

Dissociation between pituitary and adrenal suppression to dexamethasone in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2896%2980022-7

7 January 2021

10.1016/S0950-3579(96)80022-7

Identifiers

DOI

1 reference

28 September 2017

1 reference